基于超声的影像组学列线图鉴别三阴性乳腺癌与纤维腺瘤
本研究纳入182例经病理证实的纤维腺瘤和178例经病理证实的TNBC,随机分为训练队列(n=253)和验证队列(n=107),基于术前超声提取影像组学特征构建Rad-score,并结合常规超声与临床特征建立列线图。列线图在训练队列AUC 0.986(95%CI 0.975-0.997)、验证队列AUC 0.977(95%CI 0.953-1.000),优于Rad-score和临床模型(p<0.05)。
要点
- 列线图鉴别TNBC与纤维腺瘤验证队列AUC 0.977(95%CI 0.953-1.000)。
- 列线图诊断效能优于Rad-score和临床模型(p<0.05)。
- Rad-score由12个入选影像组学特征构成,为独立预测指标。
核心结论
- 影像组学特征(Rad-score)是鉴别TNBC与纤维腺瘤的潜在预测指标,结合Rad-score、常规超声特征和临床数据的列线图优于Rad-score和临床模型。
研究设计与样本
- 回顾性研究,纳入182例病理证实的纤维腺瘤和178例病理证实的TNBC,随机分为训练队列(n=253)和验证队列(n=107),基于术前超声勾画感兴趣区提取影像组学特征。
诊断标准与关键数值
- Rad-score由12个入选影像组学特征构成;列线图训练队列AUC 0.986(95%CI 0.975-0.997),验证队列AUC 0.977(95%CI 0.953-1.000),优于Rad-score和临床模型(p<0.05)。
临床应用与阅片要点
- 列线图结合Rad-score、常规超声特征和临床数据,可用于鉴别TNBC与纤维腺瘤;校准曲线和决策曲线分析显示列线图具有良好的临床实用性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to develop a radiomics nomogram that incorporates radiomics, conventional ultrasound (US) and clinical features in order to differentiate triple-negative breast cancer (TNBC) from fibroadenoma.
METHODS: A total of 182 pathology-proven fibroadenomas and 178 pathology-proven TNBCs, which underwent preoperative US examination, were involved and randomly divided into training (n = 253) and validation cohorts (n = 107). The radiomics features were extracted from the regions of interest of all lesions, which were delineated on the basis of preoperative US examination. The least absolute shrinkage and selection operator model and the maximum relevance minimum redundancy algorithm were established for the selection of tumor status-related features and construction of radiomics signature (Rad-score). Then, multivariate logistic regression analyses were utilized to develop a radiomics model by incorporating the radiomics signature and clinical findings. Finally, the usefulness of the combined nomogram was assessed by using the receiver operator characteristic curve, calibration curve, and decision curve analysis (DCA).
RESULTS: The radiomics signature, composed of 12 selected features, achieved good diagnostic performance. The nomogram incorporated with radiomics signature and clinical data showed favorable diagnostic efficacy in the training cohort (AUC 0.986, 95% CI, 0.975-0.997) and validation cohort (AUC 0.977, 95% CI, 0.953-1.000). The radiomics nomogram outperformed the Rad-score and clinical models (p < 0.05). The calibration curve and DCA demonstrated the good clinical utility of the combined radiomics nomogram.
CONCLUSION: The radiomics signature is a potential predictive indicator for differentiating TNBC and fibroadenoma. The radiomics nomogram associated with Rad-score, US conventional features, and clinical data outperformed the Rad-score and clinical models.
ADVANCES IN KNOWLEDGE: Recent advances in radiomics-based US are increasingly showing potential for improved diagnosis, assessment of therapeutic response and disease prediction in oncology. Rad-score is an independent predictive indicator for differentiating TNBC and fibroadenoma. The radiomics nomogram associated with Rad-score, US conventional features, and clinical data outperformed the Rad-score and clinical models.
引用
- Du, Zha, Wang, et al. Ultrasound-based radiomics nomogram for differentiation of triple-negative breast cancer from fibroadenoma. Br J Radiol. 2022. PMID: 35138938. doi:10.1259/bjr.20210598
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。